SCHEMBL5515745

SCHEMBL5515745

CCCCCCCCCCCCCCCCCCCC[C](O)CCCCCCCCCCCCCCCCCCCO

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.68
ALDH1A1 P00352 4/20 0.68
LMNA P02545 2/20 0.68
HSD17B10 Q99714 2/20 0.68
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
SMN1; SMN2 Q16637 1/20 0.63
GPR84 Q9NQS5 8/20 0.50
PPARG P37231 7/20 0.50
PPARD Q03181 7/20 0.50
PPARA Q07869 7/20 0.50
HDAC11 Q96DB2 5/20 0.50
PTPN1 P18031 3/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
ESR1 P03372 1/20 0.50
ALOX15 P16050 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6816127 1.00 TSHR (0.68) TSHRALDH1A1LMNAHSD17B10MEN1
SCHEMBL5519538 1.00 TSHR (0.68) TSHRALDH1A1LMNAHSD17B10MEN1
SCHEMBL5519415 1.00 TSHR (0.68) TSHRALDH1A1LMNAHSD17B10MEN1
SCHEMBL7980391 1.00 TSHR (0.68) TSHRALDH1A1LMNAHSD17B10MEN1
SCHEMBL5514816 1.00 TSHR (0.68) TSHRALDH1A1LMNAHSD17B10MEN1
SCHEMBL5518161 1.00 TSHR (0.68) TSHRALDH1A1LMNAHSD17B10MEN1
SCHEMBL9355931 0.95 TSHR (0.60) TSHRALDH1A1LMNAHSD17B10MEN1
SCHEMBL7048899 0.92 SMN1; SMN2 (0.58) TSHRALDH1A1LMNAHSD17B10MEN1
SCHEMBL9472853 0.90 TSHR (0.52) TSHRALDH1A1LMNAHSD17B10MEN1
SCHEMBL9522060 0.89 GPR84 (0.60) TSHRALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070042030-A1 Preparation for the application of agents in mini-droplets IDEA AG (DE) 2007-02-22 US disclosed
US-6165500-A Preparation for the application of agents in mini-droplets IDEA AG (DE) 2000-12-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070042030-A1 Preparation for the application of agents in mini-droplets FABP4, NPC1L1, LIPA TSHR 2808/4885ALDH1A1 3560/4885LMNA 327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.